Skip to main content
letter
. 2022 Oct 29;39(4):190–192. doi: 10.4103/joc.joc_211_21

Figure 2.

Figure 2

[a-f] Immunocytochemistry; (a) CD56 showing membranous positivity; (b) desmin showing cytoplasmic positivity in large neoplastic cells; (c) myogenin showing diffuse and strong nuclear positivity; (d-e) Ki67 and myoD1 showing nuclear positivity; (f) CD 45 showing negative staining